Mass Balance Study of ASP1941

Astellas

Status and phase: Completed; Phase 1

Conditions: Healthy Subjects

Treatments: Drug: ASP1941

Study type: Interventional

Funder types: Industry

Identifiers

NCT01302132

2008-000316-33 (EudraCT Number)

1941-CL-0055

Details and patient eligibility

About

This study investigates the pharmacokinetics, in particular the routes and extent of metabolism and excretion, of ASP1941 after a single oral dose.

Enrollment: 6 patients

Sex: Male

Ages: 18 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Body weight between 60-100kg, BMI between 18.5-30 kg/m2, inclusive

Exclusion criteria

• Pulse <40 or >90 bpm; Systolic Blood Pressure > 140 mmHg; Diastolic Blood Pressure >90 mmHg